Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 126.85M | 114.48M | 88.01M | 66.35M | 30.32M |
| Total Depreciation and Amortization | 21.55M | 20.83M | 21.48M | 21.42M | 22.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.81M | 43.13M | 56.19M | 50.84M | 67.19M |
| Change in Net Operating Assets | -3.32M | -62.00K | 475.00K | -2.30M | -11.63M |
| Cash from Operations | 173.88M | 178.38M | 166.16M | 136.31M | 108.25M |
| Capital Expenditure | -11.94M | -12.39M | -10.82M | -9.68M | -10.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -153.19M | -- | -- | -- | 0.00 |
| Divestitures | -2.85M | -2.85M | -2.85M | -2.85M | -- |
| Other Investing Activities | -118.44M | -83.44M | -71.69M | 3.31M | -47.88M |
| Cash from Investing | -286.41M | -98.67M | -85.35M | -9.21M | -57.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.00M | 20.47M | 13.85M | 14.08M | 13.84M |
| Repurchase of Common Stock | -21.12M | -20.13M | -18.22M | -18.30M | -17.92M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -4.50M |
| Cash from Financing | -3.12M | 338.00K | -4.37M | -4.22M | -8.58M |
| Foreign Exchange rate Adjustments | -90.00K | -12.00K | 587.00K | 719.00K | 306.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.74M | 80.03M | 77.03M | 123.60M | 42.05M |